Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome.
Ammann
A J
AJ
Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001685:Biological Factors / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000627:therapeutic use; D002648:Child; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007372:Interferons / Q000627:therapeutic use; D007378:Interleukins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001685:Biological Factors; D015704:CD4 Antigens; D003115:Colony-Stimulating Factors; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons